| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/29/2000 | WO1999066058A3 Materials and methods for amplifying and enhanced transcribing of polynucleotides in plants and portions thereof |
| 06/29/2000 | WO1999066028A3 Genes for the biosynthesis of epothilones |
| 06/29/2000 | WO1999064579A3 Corn oleosin promoter and genes encoding corn desaturases |
| 06/29/2000 | WO1999063077A3 Compositions of nucleic acid which alter ligand-binding characteristics and related methods and products |
| 06/29/2000 | WO1999055870A3 Transcription and gene expression regulators |
| 06/29/2000 | WO1999055854A3 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 06/29/2000 | WO1999049019A3 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 06/29/2000 | WO1999003881A3 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
| 06/29/2000 | WO1998059034A3 Treponema pallidum polynucleotides and sequences |
| 06/29/2000 | DE19860313A1 Screening effectiveness of agents against plant pathogens at the molecular level by determining altered gene expression |
| 06/29/2000 | DE19859971A1 New DNA sequence from Sirococcus, useful for detecting fungal pathogens in plants, particularly conifers, by amplification or hybridization |
| 06/29/2000 | DE19859780A1 Mittel zur Inhibition der Gewebsneubildung Means for inhibiting the formation of tissue |
| 06/29/2000 | DE19859459A1 Mikrosysteme zur Zellpermeation und Zellfusion Microsystems for cell permeation and cell fusion |
| 06/29/2000 | DE19859107A1 Thermostabile Polymerase aus ISS 1/1 Thermostable polymerase from ISS 1/1 |
| 06/29/2000 | DE19859056A1 New nucleic acids that inhibit expression of the CD30 antigen or ribosomal kinase rsk3, for modulating activity of, or killing, cells expressing these proteins, e.g. tumor cells |
| 06/29/2000 | DE19857302A1 Verfahren zur enantioselektiven Reduktion von 3,5-Dioxocarbonsäuren und deren Ester A process for the enantioselective reduction of 3,5-Dioxocarbonsäuren and esters thereof |
| 06/29/2000 | DE19856064A1 Universelles Verfahren zur Isolierung von DNA aus beliebigen Ausgangsmaterialien Universal method for the isolation of DNA from any starting materials |
| 06/29/2000 | DE19854195A1 Verfahren zur Identifikation der Funktion von biologischen Molekülen und Vorrichtung zur Durchführung des Verfahrens A method for identifying the function of biological molecules and apparatus for carrying out the method |
| 06/29/2000 | CA2776920A1 Method for producing ascorbic acid intermediates |
| 06/29/2000 | CA2578463A1 S-adenosyl-l-methionine synthetase promoter and its use in expression of transgenic genes in plants |
| 06/29/2000 | CA2450402A1 Methods and compositions for inhibiting cancer cell growth comprising pro224 |
| 06/29/2000 | CA2361196A1 Structural basis for pterin function in nitric oxide synthase |
| 06/29/2000 | CA2359586A1 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 06/29/2000 | CA2358508A1 Therapeutic applications of flint polypeptides |
| 06/29/2000 | CA2358086A1 Protein-protein interactions in neurodegenerative disorders |
| 06/29/2000 | CA2357004A1 Expression of immunogenic hepatitis b surface antigens in transgenic plants |
| 06/29/2000 | CA2356987A1 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 06/29/2000 | CA2356765A1 Bone resorption inhibitors |
| 06/29/2000 | CA2356764A1 Type iii secretion system antigens from bordetella pertussis |
| 06/29/2000 | CA2356738A1 Monoclonal antibody against apolipoprotein a-1 |
| 06/29/2000 | CA2356244A1 Somatic cells with ablated prp gene and methods of use |
| 06/29/2000 | CA2356215A1 Human monoclonal antibodies to ctla-4 |
| 06/29/2000 | CA2356155A1 Cell lineage markers |
| 06/29/2000 | CA2355968A1 Novel protein and dna thereof |
| 06/29/2000 | CA2355896A1 Antibodies to truncated vegf-d and uses thereof |
| 06/29/2000 | CA2355882A1 Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same |
| 06/29/2000 | CA2355876A1 Chlamydia trachomatis antigens |
| 06/29/2000 | CA2355874A1 .alpha.v.beta.6 integrin inhibitors |
| 06/29/2000 | CA2355836A1 Genetic suppressor elements against human immunodeficiency virus |
| 06/29/2000 | CA2355680A1 Improved recombinant hepatitis b surface antigen |
| 06/29/2000 | CA2355631A1 Msh5 ablated mice and uses therefor |
| 06/29/2000 | CA2355604A1 Novel variant egiii-like cellulase compositions |
| 06/29/2000 | CA2355402A1 Recombinant synthesis of beta-lipotropin and other peptides |
| 06/29/2000 | CA2355228A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues |
| 06/29/2000 | CA2355074A1 Lymphocytic membrane proteins |
| 06/29/2000 | CA2354846A1 Method of enhancing the biological activity of ligands |
| 06/29/2000 | CA2354843A1 Outer surface proteins, their genes, and their use |
| 06/29/2000 | CA2354736A1 Method of producing antihypercholesterolemic agents |
| 06/29/2000 | CA2354682A1 Method for the detection of specific nucleic acid sequences by polymerase nucleotide incorporation |
| 06/29/2000 | CA2354369A1 Complementary dna's encoding proteins with signal peptides |
| 06/29/2000 | CA2354185A1 Transgenic plants and methods for production thereof |
| 06/29/2000 | CA2354135A1 Group b streptococcus proteins, and their use |
| 06/29/2000 | CA2354074A1 Method of identifying a psychotropic agent using differential gene expression |
| 06/29/2000 | CA2354030A1 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
| 06/29/2000 | CA2353960A1 Improvement of tolerance to a xenograft |
| 06/29/2000 | CA2353799A1 Methods and compositions for inhibiting neoplastic cell growth |
| 06/29/2000 | CA2353790A1 Non-viral transfection vector |
| 06/29/2000 | CA2353775A1 Compositions and methods for the treatment of tumor |
| 06/29/2000 | CA2353461A1 Integrated portable biological detection system |
| 06/29/2000 | CA2352535A1 Method for preparing suspension of stable posiplexes |
| 06/29/2000 | CA2352488A1 Plant transformation process |
| 06/29/2000 | CA2352471A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 06/29/2000 | CA2352203A1 Bioassay for identifying estrogen receptor-.beta./.alpha. selective modulators |
| 06/29/2000 | CA2346960A1 Diagnostic and therapeutics for sepsis |
| 06/29/2000 | CA2321187A1 Rna polymerase transcription promoters and method for determining base sequence |
| 06/28/2000 | EP1013772A1 Method for preparing suspension of stable posiplexes |
| 06/28/2000 | EP1013771A1 Non-nuclear chromosomal transformation |
| 06/28/2000 | EP1013770A1 Non-viral transfection vector |
| 06/28/2000 | EP1013769A1 Process for the enzymatic preparation of amino acid derivatives with enhanced optical purity |
| 06/28/2000 | EP1013768A1 Mutant epoxide hydrolases |
| 06/28/2000 | EP1013767A1 Method of screening for agrochemicals |
| 06/28/2000 | EP1013766A2 Peptides for the detection of HIV-1-Group O |
| 06/28/2000 | EP1013765A1 Gene and method for producing L-amino acids |
| 06/28/2000 | EP1013764A1 Immunomodulators |
| 06/28/2000 | EP1013763A1 CANINE INTERLEUKIN 18, CANINE INTERLEUKIN 1$g(b) CONVERTASE, DNA SEQUENCES ENCODING THE SAME, PROCESS FOR PRODUCING INTERLE UKIN 18, AND REMEDIES FOR CANINE IMMUNOLOGICAL DISEASES |
| 06/28/2000 | EP1013762A2 Delta-like gene expressed in neuroendocrine tumors |
| 06/28/2000 | EP1013761A2 Humanized chimeric antibody directed against ganglioside GD3 |
| 06/28/2000 | EP1013760A2 Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same |
| 06/28/2000 | EP1013759A1 Method and apparatus for predicting protein function site, method for improving protein function, and function-improved protein |
| 06/28/2000 | EP1013758A2 Novel carbonyl reductase, method for producing said enzyme, DNA encoding said enzyme, and method for producing alcohol using said enzyme |
| 06/28/2000 | EP1013757A2 Attenuated forms of bovine viral diarrhea virus |
| 06/28/2000 | EP1013667A2 Process for preparation of cytokine using a sendai virus expression system |
| 06/28/2000 | EP1013666A2 Methods for obtaining a p53/p90 complex |
| 06/28/2000 | EP1013665A1 Novel polypeptide having water channel activity and dna sequence |
| 06/28/2000 | EP1013661A1 Novel bicyclonucleoside and oligonucleotide analogues |
| 06/28/2000 | EP1013288A2 Erythropoietin in the treatment of domestic and livestock animals for anemia |
| 06/28/2000 | EP1013287A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/28/2000 | EP1013285A2 Urokinase-type plasminogen activator receptor |
| 06/28/2000 | EP1013284A2 Purified forms of dnase |
| 06/28/2000 | EP1012749A1 Alignment-based similarity scoring methods for quantifying the differences between related biopolymer sequences |
| 06/28/2000 | EP1012564A1 Method of making high density arrays |
| 06/28/2000 | EP1012347A1 Determination and control of bimolecular interactions |
| 06/28/2000 | EP1012345A1 A METHOD FOR DETERMINING THE $i(IN VIVO) FUNCTION OF DNA CODING SEQUENCES |
| 06/28/2000 | EP1012344A1 Non-competitive co-amplification methods |
| 06/28/2000 | EP1012343A1 Reagents and methods useful for detecting diseases of the prostate |
| 06/28/2000 | EP1012341A1 An alpha-2 macroglobulin diagnostic test |
| 06/28/2000 | EP1012339A1 Method for determining propensity for developing late-onset alzheimer's disease |
| 06/28/2000 | EP1012338A1 A tumor suppressor designated ts10q23.3 |
| 06/28/2000 | EP1012337A1 Diagnosis of ocular pathogens |
| 06/28/2000 | EP1012336A1 Screening method for determining individuals at risk of developing diseases associated with different polymorphic forms of wildtype p53 |